Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
PSXP Phillips 66 Partners LP
EQ Equillium Inc
TSLA Tesla Inc
OPK OPKO Health Inc
PNW Pinnacle West Capital Corp
ROLL RBC Bearings Inc
GLAD Gladstone Capital Corp
PAC Grupo Aeroportuario del Pacifico SAB de CV
HQDA HQDA Elderly Life Network Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Closing Price
$75.21
Day's Change
-0.68 (-0.90%)
Bid
--
Ask
--
B/A Size
--
Day's High
75.89
Day's Low
73.94
Volume
(Heavy Day)
Volume:
10,589,124

10-day average volume:
8,804,460
10,589,124

Latest Earnings (Q3 ending 09/2020)

Q3
$1.74
Q3 Consensus estimate
$1.44

Latest Earnings Estimate Range

Highest
estimate
$1.52
Mean
estimate
$1.44
Lowest
estimate
$1.19

Quarterly Consensus Estimates and Ranges

MRK's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.